Health Tech Enterprise has appointed Stuart Thomson as its third co-founder and Director of Technology Commercialisation, strengthening its support for NHS staff developing technologies to improve patient care.
Stuart joins fellow co-founders Dr Anne Blackwood, Chief Executive Officer, and Max Bardwell, completing the leadership team announced in August following the introduction of the company’s new ownership structure.
He will lead Health Tech Enterprise’s NHS innovation services, working with its network of NHS Trusts to identify, protect, develop and commercialise ideas emerging from clinical practice. His focus will be on technologies with the potential to improve patient outcomes and become commercially viable products.
Stuart brings extensive experience in healthcare innovation and commercialisation. He most recently led Medovate, taking clinically led innovations in the areas of anaesthesia, intensive care, urology and surgery to international markets. His appointment builds on Health Tech Enterprise’s 20 years of experience helping NHS staff turn ideas into products that reach patients.
Dr Anne Blackwood, Chief Executive Officer and co-founder of Health Tech Enterprise, said: “Stuart brings valuable experience of taking NHS innovations through development and into international markets. He understands both the challenges clinical innovators face and what it takes to turn a promising idea into a product.
“We are delighted to welcome him as our third co-founder. His expertise will strengthen the support we provide to our NHS partners and help us take more innovations forward.”
The appointment follows a change in ownership that took effect on 1 August 2026 to support the company’s long-term growth and strengthen employee participation in the business. The new business structure will enable new potential investment and funding models to support the businesses portfolio of NHS medical innovations.
Health Tech Enterprise continues to operate under the same brand, with continuity across its services, client relationships and day-to-day operations.
Stuart Thomson, co-founder and Director of Technology Commercialisation, said: “NHS staff see opportunities to improve care every day, but developing an idea and bringing it to market takes specialist support, time and the right partners.
“Health Tech Enterprise has a long track record of helping clinicians navigate that process. I’m looking forward to working with the team and our NHS partners to identify promising technologies, support their development and find commercial routes that help them reach and benefit patients in the UK and internationally.”
The leadership team will be supported by a new NHS Advisory Board comprising representatives from NHS organisations that work with Health Tech Enterprise. The board will help ensure NHS needs and client perspectives continue to inform the company’s direction as it grows.